Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06377982
PHASE1
Human Umbilical Cord Blood Infusion in Patients with Cerebral Palsy
Sponsor: StemCyte Taiwan Co., Ltd.
View on ClinicalTrials.gov
Summary
A phase I, randomized, double-blind, placebo-controlled clinical study to assess the safety and efficacy of allogeneic human umbilical cord blood infusion in children with cerebral palsy
Official title: A Phase I, Randomized, Double-blind, Placebo-controlled Clinical Study to Assess the Safety and Efficacy of Allogeneic Human Umbilical Cord Blood Infusion in Children with Cerebral Palsy
Key Details
Gender
All
Age Range
1 Year - 18 Years
Study Type
INTERVENTIONAL
Enrollment
12
Start Date
2025-09
Completion Date
2028-12
Last Updated
2025-02-27
Healthy Volunteers
No
Conditions
Interventions
BIOLOGICAL
hUCB
hUCB